A-V

(redirected from Atrio-Ventricular)
AcronymDefinition
A-VAtrio-Ventricular
A-VArterio-Venous
A-VAccommodation-Induced Vergence (neuroscience)
References in periodicals archive ?
A 55-years-old Caucasian male with dilated cardiomyopathy and depressed left ventricle ejection fraction (LVEF) (about 37%) was implanted with a bicameral pacemaker (PM) because of a second degree atrio-ventricular block complicating a myocardial infarction.
NEXTERONE is contraindicated in patients with: known hypersensitivity to any of the components of NEXTERONE, including iodine, or in patients with cardiogenic shock, marked sinus bradycardia, and second- or third-degree atrio-ventricular (AV) block unless a functioning pacemaker is available.
Biventricular pacing ICDs may have been placed to resynchronise atrio-ventricular contraction and improve cardiac output.
The ablation group included 14 with left accessory pathways, 7 with right accessory pathways, 12 with atrio-ventricular nodal reentry tachycardia, 13 with atrial flutter or fibrillation, and 5 with ventricular tachycardia.
The maintenance of intact ATP molecules in solution is critical for the unique bradycardic effects of ATP, in particular its blockade of atrio-ventricular nodal conduction.
Although there is no previous report of significant haemodynamic disturbance following PEI for SVH, Ferlitsch and colleagues (10) have reported sinoatrial and atrio-ventricular block in 42% of patients following PEI for hepatocellular carcinoma and attributed the development of heart blocks to vasovagal reactions and the direct effect of ethanol on the sinus node or the right atrial conduction system.
PARADYM DR also includes the SafeR[TM] function which allows spontaneous atrio-ventricular conduction, while managing all three types of heart block (first, second and third degree).
The maintenance of intact ATP molecules in the solution is critical for the unique bradycardic effects of ATP, in particular its blockade of atrio-ventricular (AV) nodal conduction.
The objective of the NATURE study is to observe the evolution of atrio-ventricular conduction disorders in pacemaker patients over a 2-year time period.